SMTL ID : 4cox.1 (1 other biounit)

CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A NON-SELECTIVE INHIBITOR, INDOMETHACIN

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

homo-dimer

Ligands

6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain A: Y.23, E.35, N.36, T.38 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Y.23, A:E.35, A:E.35, A:N.36, A:T.38 NAG.2: 5 residues within 4Å: Chain A: E.109, N.113, Y.116, R.185 Chain B: L.207 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.185 NAG.3: 5 residues within 4Å: Chain A: Y.371, N.379, S.381, I.382, E.385 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.371, A:Y.371 NAG.6: 4 residues within 4Å: Chain B: Y.23, E.35, N.36, T.38 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:E.35 Hydrogen bonds: B:E.35, B:E.35, B:E.35, B:N.36, B:T.38 NAG.7: 6 residues within 4Å: Chain A: L.207 Chain B: E.109, N.113, S.115, Y.116, R.185 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:S.115, B:S.115, B:Y.116, B:R.185 NAG.8: 5 residues within 4Å: Chain B: Y.371, N.379, S.381, I.382, E.385 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:Y.371, B:Y.371

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.4: 17 residues within 4Å: Chain A: Y.117, A.168, Q.172, H.176, F.179, K.180, T.181, V.264, N.351, Y.354, H.355, W.356, H.357, L.360, V.416, A.419, Q.423 15 PLIP interactions: 15 interactions with chain A, Hydrophobic interactions: A:Q.172, A:F.179, A:F.179, A:V.264, A:Y.354, A:W.356, A:L.360, A:V.416 Hydrogen bonds: A:Y.117, A:T.181, A:N.351, A:Q.423 Salt bridges: A:H.183 pi-Stacking: A:H.176 Metal complexes: A:H.357 HEM.9: 17 residues within 4Å: Chain B: A.168, A.171, Q.172, H.176, F.179, T.181, V.264, N.351, Y.354, H.355, W.356, H.357, L.360, L.377, V.416, A.419, Q.423 16 PLIP interactions: 16 interactions with chain B, Hydrophobic interactions: B:Q.172, B:Q.172, B:F.179, B:V.264, B:W.356, B:L.360, B:L.377, B:V.416, B:V.416 Hydrogen bonds: B:T.181, B:T.181, B:N.351, B:Q.423 Salt bridges: B:H.183 pi-Stacking: B:H.176 Metal complexes: B:H.357

2 x IMN: INDOMETHACIN(Non-covalent)

IMN.5: 15 residues within 4Å: Chain A: R.89, V.318, L.321, S.322, Y.324, F.350, L.353, Y.354, W.356, M.491, V.492, G.495, A.496, S.499, L.500 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Y.354, A:W.356, A:V.492, A:V.492, A:L.500 Hydrogen bonds: A:Y.324, A:S.499 Salt bridges: A:R.89 IMN.10: 14 residues within 4Å: Chain B: R.89, V.318, L.321, S.322, Y.324, L.353, Y.354, W.356, M.491, V.492, G.495, A.496, S.499, L.500 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:V.318, B:Y.354, B:W.356, B:V.492, B:V.492, B:L.500 Hydrogen bonds: B:Y.324, B:S.499 Salt bridges: B:R.89

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kurumbail, R.G. et al., Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature (1996)

Release Date

1997-12-24

Peptides

CYCLOOXYGENASE-2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CYCLOOXYGENASE-2

Related Entries With Identical Sequence